Mounjaro Finally Launched in Korea! How Is It Different from Wegovy?

This summer,

there is news many people have been waiting for.

The weight-loss injection ‘Mounjaro’ has

been launched in Korea in mid-August.

Until now, Saxenda and Wegovy

have been used as the 대표적인 obesity treatment injections.

With the launch of Mounjaro,

a new option has become available.

So how is Mounjaro

different from existing medications?

Mounjaro is

a once-weekly subcutaneous injection developed by

U.S. pharmaceutical company Eli Lilly.

It was originally approved first

as a treatment for type 2 diabetes,

but as research findings continued to show

excellent weight-loss effects,

it also began drawing attention

in the obesity treatment market.

Its biggest feature is that it is a

‘dual agonist’ that simultaneously stimulates

two hormone receptors, GLP-1 and GIP.

Mounjaro features

When food is consumed, GIP

stimulates the beta cells of the pancreas

to promote insulin secretion.

It helps prevent blood sugar from

rising sharply after meals,

and plays a role in helping blood sugar

remain stable.

In particular, for patients with type 2 diabetes,

because blood sugar control is also achieved,

it can accomplish two goals at once:

weight loss and blood sugar management.

GIP does not simply

increase insulin;

it also promotes metabolic activity in fat cells and muscle cells.

The effect goes beyond simply reducing food intake,

meaning it shifts the body to use stored fat as energy,

which is more favorable for weight loss.

If GLP-1 is responsible for ‘appetite suppression,’

GIP helps with ‘metabolic improvement.’

Unlike a diet that simply reduces meal portions,

it lowers the possibility of rebound weight gain

and helps with long-term weight maintenance.

✅ In summary,

GLP-1 plays the role of ‘making you eat less’

GIP plays the role of ‘efficiently burning what you eat and stored fat’

👉 By combining the two, Mounjaro shows a stronger weight-loss effect.

👉 In summary,

in terms of effectiveness,

Mounjaro is one step ahead,

but the types of side effects are not greatly different.

Mounjaro’s launch in Korea

can be a new opportunity for many people

who are considering weight loss.

However, all weight-loss injections should be used

with consideration of an individual’s health condition and lifestyle,

so it is safest and most effective

to make a decision after 충분히 consulting with a specialist.